Suppr超能文献

胰岛素受体底物 2 的耗竭逆转了 v-src 诱导的致癌转化。

Depletion of insulin receptor substrate 2 reverses oncogenic transformation induced by v-src.

机构信息

Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Medical School of Xi'an Jiaotong University, Xi'an 710061, China.

出版信息

Acta Pharmacol Sin. 2011 May;32(5):611-8. doi: 10.1038/aps.2011.18. Epub 2011 May 2.

Abstract

AIM

To investigate the role of insulin receptor substrate 2 (IRS-2) in oncogenic transformation induced by v-src.

METHODS

IRS-2 gene was silenced using small interfering RNAs (siRNAs). Nuclear translocation and interaction of IRS-2 with v-src was determined using subcellular fractionation, confocal microscopy, and immunoprecipitation. The activity of the cyclin D1 promoter and r-DNA promoter was measured with a luciferase assay.

RESULTS

Depletion of IRS-2 inhibited R-/v-src cell growth and reverse the oncogenic transformation. IRS-2 bound to src via its two PI3-K binding sites, which are critical for activities involved in the transformation. Nuclear IRS-2 occupied the cyclin D1 and rDNA promoters. The combination of IRS-2 and v-src increased the activity of the two promoters, especially the rDNA promoter.

CONCLUSION

Depletion of insulin receptor substrate 2 could reverse oncogenic transformation induced by v-src.

摘要

目的

研究胰岛素受体底物 2(IRS-2)在 v-src 诱导的致癌转化中的作用。

方法

使用小干扰 RNA(siRNA)沉默 IRS-2 基因。使用亚细胞分级分离、共聚焦显微镜和免疫沉淀来确定 IRS-2 与 v-src 的核易位和相互作用。通过荧光素酶测定法测量细胞周期蛋白 D1 启动子和 r-DNA 启动子的活性。

结果

IRS-2 的耗竭抑制了 R-/v-src 细胞的生长并逆转了致癌转化。IRS-2 通过其两个 PI3-K 结合位点与 src 结合,这对于参与转化的活性至关重要。核 IRS-2 占据了细胞周期蛋白 D1 和 rDNA 启动子。IRS-2 和 v-src 的结合增加了两个启动子的活性,特别是 rDNA 启动子的活性。

结论

IRS-2 的耗竭可以逆转 v-src 诱导的致癌转化。

相似文献

1
Depletion of insulin receptor substrate 2 reverses oncogenic transformation induced by v-src.
Acta Pharmacol Sin. 2011 May;32(5):611-8. doi: 10.1038/aps.2011.18. Epub 2011 May 2.
2
The role of insulin receptor substrate-1 in transformation by v-src.
J Cell Physiol. 2008 Jun;215(3):725-32. doi: 10.1002/jcp.21352.
6
Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2.
Mol Endocrinol. 2003 Mar;17(3):472-86. doi: 10.1210/me.2002-0276. Epub 2002 Dec 6.
7
Nuclear insulin receptor substrate-1 activates promoters of cell cycle progression genes.
Oncogene. 2008 Jan 10;27(3):397-403. doi: 10.1038/sj.onc.1210636. Epub 2007 Aug 13.
9
JunD/AP-1 Antagonizes the Induction of DAPK1 To Promote the Survival of v-Src-Transformed Cells.
J Virol. 2016 Dec 16;91(1). doi: 10.1128/JVI.01925-16. Print 2017 Jan 1.

引用本文的文献

1
Aflatoxin B1 induces Src phosphorylation and stimulates lung cancer cell migration.
Tumour Biol. 2015 Aug;36(8):6507-13. doi: 10.1007/s13277-015-3341-2. Epub 2015 Mar 29.

本文引用的文献

1
Customizing the targeting of IGF-1 receptor.
Future Oncol. 2009 Feb;5(1):43-50. doi: 10.2217/14796694.5.1.43.
2
The role of insulin receptor substrate-1 in transformation by v-src.
J Cell Physiol. 2008 Jun;215(3):725-32. doi: 10.1002/jcp.21352.
3
Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2.
Cell Cycle. 2007 Mar 15;6(6):705-13. doi: 10.4161/cc.6.6.4035. Epub 2007 Mar 20.
4
Insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer cells.
Cancer Res. 2007 Mar 1;67(5):2124-30. doi: 10.1158/0008-5472.CAN-06-3954.
5
A mechanism for cell size regulation by the insulin and insulin-like growth factor-I receptors.
Cancer Res. 2006 Dec 1;66(23):11106-9. doi: 10.1158/0008-5472.CAN-06-2641.
8
The insulin-like growth factor-I receptor as a target for cancer therapy.
Expert Opin Ther Targets. 2005 Aug;9(4):753-68. doi: 10.1517/14728222.9.4.753.
9
Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in l6 myotubes.
J Biol Chem. 2005 May 13;280(19):19426-35. doi: 10.1074/jbc.M412317200. Epub 2005 Mar 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验